Arcellx Inc's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Arcellx Inc's ROI in the fourth quarter of 2025?
Arcellx Inc recorded a cumulative net loss of $-229 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on investment (ROI) of -44.23%.

Within the Healthcare sector 505 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from 3125 to 3864.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Investment Change TTM	-18.23 %	-18.71 %	-8.89 %	4.73 %	22.17 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	500	538	497	536	586
Return On Investment (TTM)	-44.23 %	-40.42 %	-33.47 %	-27.12 %	-16.96 %
ACLX's Overall Ranking	# 3864	# 3125	# 2884	# 2646	# 1991
Seq. Investment Change TTM	-3.99 %	-4.02 %	-6.21 %	-5.38 %	-4.56 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-229	-218	-188	-162	-107

ACLX Company Profile >> Back to ACLX Roi Comparisons >> See Annual ACLX Return On Investment

Return On Investment ACLX's Ranking
Within:	No.
Industry	# 73
Sector	# 506
Overall	# 3864

Return On Investment Statistics
High	Average	Low
-6.1 %	-32.04 %	-66.6 %
(Sep 30 2024)		(Dec 31 2022)

Financial Statements
Arcellx Inc's IV. Quarter Investments	$ 500 Millions	ACLX's Balance sheet
Arcellx Inc's IV. Quarter Income	$ -58 Millions	Quarterly ACLX's Income Statement
ACLX's Income by Division		See ACLX's Income by Division

ACLX Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022
Total Investments in Millions	500	586	707	257	0
Y / Y Investment Growth	-14.7 %	-17.11 %	174.92 %	-	-
Net Income in Millions	-229	-107	-71	-189	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-45.81 %	-18.32 %	-10 %	-73.38 %	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ACLX's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ACLX's Competitors
Subscribers only: Roi for Arcellx Inc's Suppliers
Subscribers only: Return On Investment for ACLX's Customers

Other Ratios
ACLX's Roa	ACLX's Inventory Turnover Ratio	ACLX's Growth Rates	ACLX's Dividend Statistics
	ACLX's Profitability Ratios	ACLX's Asset Turnover Ratio	ACLX's Dividend Growth
ACLX's Roe	ACLX's Valuation Ratios	ACLX's Financial Strength Ratios	ACLX's Dividend Payout Ratio

Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector

ROI

Date modified: 2026-09-18T13:11:06+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.